These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8212302)

  • 21. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.
    Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV
    Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of infectious complications following abdominal cluster transplantation].
    Chen HX; Yin L; Peng CH; Zhou GW; Shen BY; Chen GM; Chen CQ; Zhou HJ; Li HW
    Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(5):319-22. PubMed ID: 17535710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
    Gondo H
    Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayr T; Prenner G; Hipmair G; Grasser B; Freigassner M
    J Heart Lung Transplant; 1996 Mar; 15(3):314-5. PubMed ID: 8777216
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA; Snydman DR
    Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal?
    Boeckh M; Riddell SR
    J Infect Dis; 2007 Mar; 195(5):615-7. PubMed ID: 17262699
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of cytomegalovirus in organ transplantation].
    Aguado JM
    Rev Clin Esp; 1996 Apr; 196(4):240-7. PubMed ID: 8701064
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
    Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
    Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for cytomegalovirus prophylaxis in solid organ transplantation.
    Snydman DR
    Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recommendations for the diagnosis and therapy of cytomegalovirus infection after stem-cell transplantation. The Research Alliance on the Complications of Organ Transplantation due to Herpes Viruses].
    Einsele H; Herbart H; Bock T; Müller C; Fleckenstein B; Mach M; Stamminger T; Jahn G; Sinzger C; Koszinowski U; Meyer-König U; Mertens T; Plachter B; Reddehase MJ; Schmidt CA
    Dtsch Med Wochenschr; 1999 Apr; 124(16):501-6. PubMed ID: 10341755
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytomegalovirus infections in transplant patients.
    Ljungman P
    Scand J Infect Dis Suppl; 1996; 100():59-63. PubMed ID: 8860355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining an optimal regimen for cytomegalovirus prophylaxis in organ transplant recipients.
    Paya CV
    Transplant Proc; 1996 Dec; 28(6 Suppl 2):9-11. PubMed ID: 9037269
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient.
    Ho M
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):2-7. PubMed ID: 1647559
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
    Humar A; Kumar D; Boivin G; Caliendo AM
    J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytomegalovirus pneumopathies. What role should be given to cytomegaloviruses isolated from blood and bronchoalveolar lavage fluid in AIDS and from organ and bone marrow grafts?].
    Blot F; Mayaud C; Frachon I; Couderc LJ; Stern M; Friard S; Caubarrère I
    Rev Pneumol Clin; 1995; 51(6):309-20. PubMed ID: 8746018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytomegalovirus infections following transplantation: diagnosis, prevention and treatment].
    Calain P; Lew D
    Rev Med Suisse Romande; 1988 Aug; 108(8):697-701. PubMed ID: 2847275
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytomegalovirus disease after liver transplantation: diagnostics and therapy.
    Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108
    [No Abstract]   [Full Text] [Related]  

  • 40. Ganciclovir-resistant cytomegalovirus in organ transplant recipients.
    Limaye AP
    Clin Infect Dis; 2002 Oct; 35(7):866-72. PubMed ID: 12228824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.